Amended number of shares and votes in NeuroVive Pharmaceutical AB (publ)
Lund, Sweden, 28 December 2018 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), today announced an increase of the number of shares and votes in NeuroVive of 126,235 as a result of a performed subscription options program (series 2018:1), resolved by the Board of Directors on 15 February 2018.Today, the last trading day of the month, there are in total 91,697,076 shares and votes in NeuroVive Pharmaceutical AB. This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act (1991:980).